Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Total Non-Current Liabilities (2010 - 2025)

Analysis

Cerenome (CNSY) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn 40.00 Mn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn 3.92 Bn
5 Revolution Medicines 44.41 Bn 44.41 Bn - 1.53 Bn
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn 1.88 Bn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 9.32 Bn
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn 1.17 Bn
10 Cerenome 20.42 Mn 11.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 7.32 Mn
Mar 31, 2025 10.56 Mn
Dec 31, 2021 11.14 Mn
Sep 30, 2021 9.99 Mn
Jun 30, 2021 8.88 Mn
Mar 31, 2021 8.82 Mn
Dec 31, 2020 9.07 Mn
Sep 30, 2020 4.53 Mn
Jun 30, 2020 10.36 Mn
Mar 31, 2020 15.62 Mn
Dec 31, 2019 15.14 Mn
Sep 30, 2019 15.15 Mn
Jun 30, 2019 14.74 Mn
Mar 31, 2019 20.05 Mn
Dec 31, 2018 17.85 Mn
Sep 30, 2018 17.92 Mn
Sep 30, 2016 17.27 Mn
Jun 30, 2016 18.06 Mn
Mar 31, 2016 19.17 Mn
Dec 31, 2015 25.49 Mn